ENTERA BIO LTD (ENTX) Stock Balance Sheet
USA - NASDAQ:ENTX - IL0011429839 - Common Stock
2.68 USD
-0.03 (-1.11%)
2.61 USD
-0.07 (-2.61%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | null | null | null | null | null | |||
| Cash Equivalents | 10.86M | 8.66M | 11.02M | 12.31M | 24.89M | |||
| Cash Due From Banks | null | null | null | null | null | |||
| Investments | null | null | null | null | null | |||
| Net Loans | null | null | null | null | null | |||
| Insurance Receivables | null | null | null | null | null | |||
| Marketable Securities | null | null | null | null | null | |||
| Receivables | 0 | 126.00K | 0 | 250.00K | 180.00K | |||
| Inventories | null | null | null | null | null | |||
| Other Current Assets | 8.45M | 186.00K | 238.00K | 290.00K | 250.00K | |||
| Total Current Assets | 19.31M | 8.97M | 11.26M | 12.85M | 25.33M | |||
| Non-Current Assets | ||||||||
| PPE Net | 269.00K | 332.00K | 488.00K | 230.00K | 400.00K | |||
| Investments And Advances | null | null | null | null | null | |||
| Goodwill | null | null | null | null | null | |||
| Intangibles | null | null | null | null | null | |||
| Other Non-Current Assets | 87.00K | 86.00K | 20.00K | 50.00K | 260.00K | |||
| Total Non-Current Assets | 356.00K | 418.00K | 508.00K | 280.00K | 660.00K | |||
| TOTAL ASSETS | 19.67M | 9.39M | 11.77M | 13.13M | 25.99M | |||
| LIABILITIES | ||||||||
| Total Deposits | null | null | null | null | null | |||
| Current Liabilities | ||||||||
| Short Term Borrowings | null | null | null | null | null | |||
| Short Term Debt | 0 | 0 | 0 | 0 | 0 | |||
| Current Portion Of LT Debt. | null | null | null | null | null | |||
| Accrued Expenses | 1.19M | 1.04M | 1.01M | 1.32M | 2.98M | |||
| Accounts Payable | 383.00K | 132.00K | 83.00K | 20.00K | 170.00K | |||
| Other Current Liabilities | 274.00K | null | null | 0 | 20.00K | |||
| Total Current Liabilities | 1.84M | 1.18M | 1.09M | 1.34M | 3.16M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0 | 0 | 0 | 0 | 0 | |||
| Deferred Taxes/Income | null | null | null | null | null | |||
| Other Non-Current Liabilities | 567.00K | 134.00K | 288.00K | 30.00K | 260.00K | |||
| Total Non-Current Liabilities | 567.00K | 134.00K | 288.00K | 30.00K | 260.00K | |||
| TOTAL LIABILITIES | 2.41M | 1.31M | 1.38M | 1.37M | 3.42M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -119.15M | -113.93M | -104.39M | -95.50M | -82.43M | |||
| Additional Paid In Capital | 136.36M | 121.97M | 114.73M | 107.21M | 104.95M | |||
| Minority Interest | null | null | null | null | null | |||
| Common Shares | 1.00K | 1.00K | 2.70K | null | null | |||
| Treasury Stock | null | null | null | null | null | |||
| Other Shareholders' Equity | 41.00K | 41.00K | 39.30K | 40.00K | 40.00K | |||
| Shares Outstanding | 45.45M | 38.84M | 35.48M | 28.81M | 28.80M | |||
| Tangible Book Value per Share | 0.3797 | 0.2081 | 0.2928 | 0.4078 | 0.7837 | |||
| Total Shareholders' Equity | 17.26M | 8.08M | 10.39M | 11.75M | 22.57M | |||
| TOTAL LIABILITIES AND EQUITY | 19.67M | 9.39M | 11.77M | 13.13M | 25.99M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 10.47 | 7.63 | 10.32 | 9.59 | 8.02 | |||
| Return On Assets (ROA) | -53.91% | -101.61% | -75.55% | -99.54% | -46.90% | |||
| Return On Equity (ROE) | -61.44% | -118.08% | -85.59% | -111.23% | -54.01% | |||
All data in USD , ROIC based on taxRate of 0.21